Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial
Walter, I., Schulz, U., Vogelhuber, M., Wiedmann, K., Endlicher, E., Klebl, F., Andreesen, R., Herr, W., Ghibelli, L., Hackl, C., Wiest, R. and Reichle, A. (2017) Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial. Medical Oncology 34 (12).Date of publication of this fulltext: 20 Mar 2019 13:10
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Medical Oncology | ||||
| Publisher: | HUMANA PRESS INC | ||||
|---|---|---|---|---|---|
| Place of Publication: | TOTOWA | ||||
| Volume: | 34 | ||||
| Number of Issue or Book Chapter: | 12 | ||||
| Date | 2017 | ||||
| Institutions | Medicine > Lehrstuhl für Chirurgie Medicine > Lehrstuhl für Innere Medizin I Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) | ||||
| Identification Number |
| ||||
| Keywords | ACTIVATED RECEPTOR-GAMMA; C-REACTIVE PROTEIN; THERAPEUTIC TARGET; SIGNALING PATHWAY; CLINICAL-TRIALS; CELL-GROWTH; IN-VITRO; EXPRESSION; CANCER; HEPATOCARCINOGENESIS; Hepatocellular carcinoma; Biomodulatory therapy; COX-2 inhibitor; Pioglitazone; Metronomic low-dose chemotherapy; Anakoinosis | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 39589 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric